Compositions, Articles of Manufacture and Methods for Treating Cancer
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,786,547 | Compositions, Articles of Manufacture and Methods for Treating Cancer In force · High confidence | Biolinerx Ltd. | In force | High confidence | ||
| Application 17/006,954 | Compositions, Articles of Manufacture and Methods for Treating Cancer Abandoned Abandoned Mar 17, 2023 | Biolinerx Ltd. | Abandoned | Abandoned Mar 17, 2023 |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by BioLineRx Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.